ST6GAL1 and prostate carcinoma: Additionally, ST6Gal-I also plays a significant role in cell invasion through the PI3K/Akt pathway, as evidenced by the fact that knocking down ST6Gal-I in aggressive prostate cancer cells substantially hindered their growth, proliferation, and migration capabilities by reducing the levels of several pathway components [78].